Intellipharmaceutics International Inc. (IPCI)

[Samsa]

this is why I preach caution. while I am a full believer in the company this why I preach a more conservative approach on the company. COLL is falling down the path as all others. while IPCI should easily see 400 million in market share. not all of that is going to be profit. assuming they partner with a big player like Pfizer. the cost to manufacture, distribute, market with a sales force and advertise it is not uncommon to only have a profit margin of 10 to 20% in a field where there are competitors. higher profit margins can be expected on orphan drugs but pricing competitiveness keeps profit margins down on others where they compete. and you dont hit the road running and hit that 400 million on day 1. thats 2 years down the road after launch. then of course if say 40 million in profits is seen its then split. hopefully at least 50/50. but thats where I come in at a conservative 20 million a year in revenue. don't under estimate the pricing that will need to be factored in to be competitive sort of like Generics as well as the expense the partner will have in production and distribution and marketing. COLL is just finding this out.